Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Animals And NotChristopher G. Goetz

List of bibliographic references

Number of relevant bibliographic references: 54.
Ident.Authors (with country if any)Title
000001 S. Thobois [France]USP30: a new promising target for Parkinson's disease?
000019 Mohamed Jaber [France]Autism is (also) a movement disorder.
000027 Carole Hyacinthe [France] ; Imad GhorayebWake up with a new brain!
000029 Anna Castrioto [France] ; Céline Piscicelli ; Dominic Pérennou ; Paul Krack ; Bettina DebûThe pathogenesis of Pisa syndrome in Parkinson's disease.
000032 Raul Martinez-Fernandez [France] ; Anna Castrioto ; Paul KrackPrefrontal--STN projections, the highway for emotion and cognition control.
000034 Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien CarnicellaPramipexole reverses Parkinson's disease-related motivational deficits in rats.
000038 Benjamin Dehay [France]Evidence piles Up for prion-like propagation mechanisms in synucleinopathies.
000039 Mathieu Bourdenx [France] ; Benjamin Dehay ; Erwan BezardDown-regulating α-synuclein for treating synucleopathies.
000040 Nagaraj D. Halemani [France]Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?
000043 Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. FacherisCombined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000044 Iva Stankovic [Serbie] ; Florian Krismer [Autriche] ; Aleksandar Jesic [Serbie] ; Angelo Antonini [Italie] ; Thomas Benke [Autriche] ; Richard G. Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Horacio Kaufmann [États-Unis] ; Vladimir S. Kostic [Serbie] ; Helen Ling [Royaume-Uni] ; Wassilios G. Meissner [France] ; Werner Poewe [Autriche] ; Marija Semnic [Serbie] ; Klaus Seppi [Autriche] ; Atsushi Takeda [Japon] ; Daniel Weintraub [États-Unis] ; Gregor K. Wenning [Autriche]Cognitive impairment in multiple system atrophy
000045 Olivier Flabeau [France] ; Wassilios G. Meissner ; Annaig Ozier ; Patrick Berger ; François Tison ; Pierre-Olivier FernagutBreathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy.
000048 M. Maltese [Italie] ; G. Martella [Italie] ; G. Madeo [Italie] ; I. Fagiolo [Italie] ; A. Tassone [Italie] ; G. Ponterio [Italie] ; G. Sciamanna [Italie] ; P. Burbaud [France] ; P. J. Conn [États-Unis] ; P. Bonsi [Italie] ; A. Pisani [Italie]Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors
000053 Benjamin Bessieres [France] ; Bruno Bontempi ; Olivier NicoleTiny light, big hope.
000054 Michel Engeln [France]Throwing some light on executive function in Parkinson's disease.
000060 Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000070 Benjamin Dehay [France] ; Marta Martinez-Vicente ; Guy A. Caldwell ; Kim A. Caldwell ; Zhenyue Yue ; Mark R. Cookson ; Christine Klein ; Miquel Vila ; Erwan BezardLysosomal impairment in Parkinson's disease.
000077 Marianne Benoit-Marand [France]Dopamine neurons are multi-neurotransmitter neurons.
000081 Mohamed Jaber [France]CLARITY or the invisible brain.
000085 Mathieu Bourdenx [France]Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease.
000105 Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies
000138 Benjamin Dehay [France] ; Erwan BezardNew animal models of Parkinson's disease.
000169 Anne-Sophie Rolland [France] ; Carine Karachi [France] ; Marie-Paule Muriel [France] ; Etienne C. Hirsch [France] ; Chantal François [France]Internal pallidum and substantia nigra control different parts of the mesopontine reticular formation in primate
000181 Erwan Bezard [France] ; Serge Przedborski [États-Unis]A tale on animal models of Parkinson's disease
000255 Carine Karachi [France] ; David Grabli [France] ; Nicolas Baup [France] ; Stéphanie Mounayar [France] ; Dominique Tandé [France] ; Chantal François [France] ; Etienne C. Hirsch [France]Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys
000300 Annie Lannuzel [France] ; Merle Ruberg [France] ; Patrick P. Michel [France]Atypical parkinsonism in the Caribbean island of Guadeloupe: Etiological role of the mitochondrial complex I inhibitor annonacin
000321 Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France]Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias
000370 Ruth H. Walker [États-Unis] ; Adrian Danek [Allemagne] ; Carol Dobson-Stone [Australie] ; Renzo Guerrini [Italie] ; Hans H. Jung [Suisse] ; Anne-Louise Lafontaine [Canada] ; Luca Rampoldi [Italie] ; François Tison [France] ; Eva Andermann [Canada]Developments in neuroacanthocytosis: Expanding the spectrum of choreatic syndromes
000383 Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
000392 Carine Karachi [France] ; Jérôme Yelnik [France] ; Dominique Tandé [France] ; Léon Tremblay [France] ; Etienne C. Hirsch [France] ; Chantal François [France]The pallidosubthalamic projection: An anatomical substrate for nonmotor functions of the subthalamic nucleus in primates
000399 Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb [France] ; Elsa Diguet [France] ; François Tison [France]In vivo models of multiple system atrophy
000403 Günter U. Höglinger [France] ; Patrick P. Michel [France] ; Pierre Champy [France] ; Jean Feger [France] ; Etienne C. Hirsch [France] ; Merle Ruberg [France] ; Annie Lannuzel [France]Experimental evidence for a toxic etiology of tropical parkinsonism
000450 Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique]Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset
000466 Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis]Surgery of the motor thalamus: Problems with the present nomenclatures
000468 Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation
000475 Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France]Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence
000477 Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France]Mechanisms of deep brain stimulation
000479 Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats
000486 J. Yelnik [France]Functional anatomy of the basal ganglia
000488 Anne-Catherine Bachoud-Lévi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France]Fetal neural grafts for Huntington's disease: A prospective view
000497 Frans Vanderwerf [Pays-Bas] ; Catherine Buisseret-Delmas [France] ; Pierre Buisseret [France]Afferent innervation of eyelids and their connections to the superior colliculus
000503 Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain
000513 Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Douhou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice
000519 Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France]Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration
000545 Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France]Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
000553 M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
000558 H. Widner [Suède] ; G.-L. Defer [France]Dyskinesias assessment : From CAPIT to CAPSIT
000562 Hagai Bergman ; Aeyal Raz ; Ariela Feingold ; Asaph Nini ; Israel Nelken ; Ben-Pazi Hilla ; David Hansel [France] ; Avinoam RechesPhysiology of MPTP Tremor
000566 Paul Krack [Allemagne] ; Günther Deuschl [Allemagne] ; Reiner Benecke [Allemagne] ; Andres O. Ceballos-Baumann [Allemagne] ; Marie-Hélène Marion [France] ; Rue Léon Delhomme [France] ; Wolfgang H. Oertel [Allemagne] ; Werner Poewe [Autriche] ; K. Wohlfarth [Allemagne, France, Autriche, Italie, États-Unis] ; H. Göschel [Allemagne, France, Autriche, Italie, États-Unis] ; J. Frevert [Allemagne, France, Autriche, Italie, États-Unis] ; R. Dengler [Allemagne, France, Autriche, Italie, États-Unis] ; H. Bigalke [Allemagne, France, Autriche, Italie, États-Unis] ; Pasquale Montagna [Italie] ; Elio Lugaresi [Italie] ; Stanley Fahn [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Katrina A. Gwinn [États-Unis]Letters to the Editor
000583 Mohamed Jaber [États-Unis, France] ; Sara Jones [États-Unis] ; Bruno Giros [États-Unis] ; Caron [États-Unis]The dopamine transporter: A crucial component regulating dopamine transmission
000602 Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France]Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment
000636 Rektor [France] ; M. Švejdová [France] ; C. Silva-Barrat [France] ; C. Menini [France]The cholinergic system‐dependent myoclonus of the baboon papio is a reticular reflex myoclonus
000657 Nieoullon [France] ; Lydia Kerkerian-Le Goff [France]Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: Possible functional implications
000672 J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse]Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024